338 related articles for article (PubMed ID: 29710431)
1. Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.
Darrigade AS; Legrand A; Andreu N; Jacquemin C; Boniface K; Taïeb A; Seneschal J
Br J Dermatol; 2018 Aug; 179(2):534-536. PubMed ID: 29710431
[No Abstract] [Full Text] [Related]
2. Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis.
McKenzie PL; Castelo-Soccio L
J Am Acad Dermatol; 2021 Jun; 84(6):1691-1694. PubMed ID: 33484763
[No Abstract] [Full Text] [Related]
3. Hair Regrowth in a Patient With Long-standing Alopecia Totalis and Atopic Dermatitis Treated With Dupilumab.
Penzi LR; Yasuda M; Manatis-Lornell A; Hagigeorges D; Senna MM
JAMA Dermatol; 2018 Nov; 154(11):1358-1360. PubMed ID: 30304403
[No Abstract] [Full Text] [Related]
4. Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report.
Uchida H; Kamata M; Watanabe A; Agematsu A; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
Acta Derm Venereol; 2019 Jun; 99(7):675-676. PubMed ID: 30938821
[No Abstract] [Full Text] [Related]
5. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A
Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073
[TBL] [Abstract][Full Text] [Related]
6. Onset of Schamberg Disease and Resolution of Alopecia Areata During Treatment of Atopic Dermatitis With Dupilumab.
Szekely S; Vaccari D; Salmaso R; Belloni-Fortina A; Alaibac M
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):65-66. PubMed ID: 32490817
[No Abstract] [Full Text] [Related]
7. Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis.
Carnicle JM; Hendricks AJ; Shi VY
Dermatitis; 2021 Oct; 32(1S):e80-e82. PubMed ID: 31441782
[TBL] [Abstract][Full Text] [Related]
8. [Dupilumab-Associated Healing of Alopecia Areata in an Atopic Dermatitis Patient].
Aszodi N; Pumnea T; Wollenberg A
Dtsch Med Wochenschr; 2019 May; 144(9):602-605. PubMed ID: 31026869
[TBL] [Abstract][Full Text] [Related]
9. Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata.
Gambardella A; Licata G; Calabrese G; De Rosa A; Alfano R; Argenziano G
Dermatitis; 2021 Oct; 32(1S):e85-e86. PubMed ID: 34405831
[No Abstract] [Full Text] [Related]
10. Simultaneous effectiveness of dupilumab in atopic dermatitis and alopecia areata in two patients.
Ludriksone L; Elsner P; Schliemann S
J Dtsch Dermatol Ges; 2019 Dec; 17(12):1278-1280. PubMed ID: 31829527
[No Abstract] [Full Text] [Related]
11. Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab.
Barroso-García B; Rial MJ; Molina A; Sastre J
J Investig Allergol Clin Immunol; 2018 Dec; 28(6):420-421. PubMed ID: 30530389
[No Abstract] [Full Text] [Related]
12. Cyclosporin A and alopecia areata.
Moreno JC; Ocaña MS; Vélez A
J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):417-8. PubMed ID: 12224710
[No Abstract] [Full Text] [Related]
13. Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata.
Tavoletti G; Chiei-Gallo A; Barei F; Marzano AV; Ferrucci SM
Int J Dermatol; 2024 Mar; 63(3):374-375. PubMed ID: 38197323
[No Abstract] [Full Text] [Related]
14. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
[TBL] [Abstract][Full Text] [Related]
15. Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study.
Oosterhaven JAF; Voorberg AN; Romeijn GLE; de Bruin-Weller MS; Schuttelaar MLA
J Dermatol; 2019 Aug; 46(8):680-685. PubMed ID: 31187925
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.
Thaçi D; Simpson EL; Beck LA; Bieber T; Blauvelt A; Papp K; Soong W; Worm M; Szepietowski JC; Sofen H; Kawashima M; Wu R; Weinstein SP; Graham NM; Pirozzi G; Teper A; Sutherland ER; Mastey V; Stahl N; Yancopoulos GD; Ardeleanu M
Lancet; 2016 Jan; 387(10013):40-52. PubMed ID: 26454361
[TBL] [Abstract][Full Text] [Related]
17. Dupilumab and alopecia: A Janus effect.
Patruno C; Napolitano M; Ferrillo M; Fabbrocini G
Dermatol Ther; 2019 Sep; 32(5):e13023. PubMed ID: 31306557
[TBL] [Abstract][Full Text] [Related]
18. Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata.
Ito T; Kageyama R; Nakazawa S; Honda T
Exp Dermatol; 2020 Aug; 29(8):726-732. PubMed ID: 32533873
[TBL] [Abstract][Full Text] [Related]
19. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
Hendricks AJ; Yosipovitch G; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
[No Abstract] [Full Text] [Related]
20. Dupilumab in Dermatology: Potential for Uses Beyond Atopic Dermatitis.
Maloney NJ; Tegtmeyer K; Zhao J; Worswick S
J Drugs Dermatol; 2019 Oct; 18(10):. PubMed ID: 31603635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
